Data gathered: November 30
Alternative Data for China SXT Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 73 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 15,634 | Sign up | Sign up | Sign up |
| Twitter Mentions | 13 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the research, development, manufacture, marketing and sale of Traditional Chinese Medicine Tablets (TCMP) in China. The company is headquartered in Taizhou, China.
| Price | $0.40 |
| Target Price | Sign up |
| Volume | 26,720 |
| Market Cap | $1.6M |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
China SXT Pharmaceuticals (NASDAQ:SXTC) versus Aquestive Therapeutics (NASDAQ:AQST) Head-To-Head ContrastNovember 5 - ETF Daily News |
SXTC Stock Dips Amidst Pharma Sector GrowthOctober 24 - GuruFocus |
|
China SXT Pharmaceuticals files for $120M mixed securities shelfOctober 21 - Seeking Alpha |
|
China SXT Pharmaceuticals files $120M mixed securities shelfOctober 21 - TipRanks |
|
SXTC Stock Surges 6.3% Amidst Volatile Trading in the Pharmaceutical SectorOctober 20 - GuruFocus |
|
SXTC Stock Surges with a 6.49% Jump Amidst Market ActivityOctober 16 - GuruFocus |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 490,000 | 360,000 | 130,000 | 3.3M | 3.7M | |
| Q1 '24 | 0 | 0 | 0 | 0 | 0 | |
| Q4 '23 | 490,000 | 360,000 | 130,000 | 3.3M | 3.7M | |
| Q3 '23 | 940,000 | 750,000 | 190,000 | -9.7M | -4.6M | |
| Q2 '23 | 470,000 | 330,000 | 140,000 | -4.8M | -4.6M |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about China SXT Pharmaceuticals (SXTC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of China SXT Pharmaceuticals?
The Market Cap of China SXT Pharmaceuticals is $1.6M.
What is the current stock price of China SXT Pharmaceuticals?
Currently, the price of one share of China SXT Pharmaceuticals stock is $0.40.
How can I analyze the SXTC stock price chart for investment decisions?
The SXTC stock price chart above provides a comprehensive visual representation of China SXT Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling China SXT Pharmaceuticals shares. Our platform offers an up-to-date SXTC stock price chart, along with technical data analysis and alternative data insights.
Does SXTC offer dividends to its shareholders?
As of our latest update, China SXT Pharmaceuticals (SXTC) does not offer dividends to its shareholders. Investors interested in China SXT Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of China SXT Pharmaceuticals?
Some of the similar stocks of China SXT Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.